RxDoctor Payments Data

Sara Matherly, NP

Adult Health · Newport News, VANPI 1750811469

Payments from drug & device makers

$275in general payments, 2019–2025

Across 12 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$48
  • Boston Scientific$45
  • Coloplast$35
  • Novartis$32
  • Procept Biorobotics Corporation$27
  • Endo USA, Inc.$25
  • plus $64 from 3 others

What the payments were for

  • Food & beverage$275100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$275 in reported general payments places this provider in the 40th percentile of 368 adult health providers in Virginia.

See all adult health providers in Virginia

Medicare billing

Part B allowed, 2024
$57,945
Medicare patients
602
Services billed
1,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron114$99,971
GemtesaVibegron27$21,572
Trospium Chloride ErTrospium Chloride29$7,254
Testosterone29$5,933
Tolterodine Tartrate ErTolterodine Tartrate17$3,732
Solifenacin Succinate79$3,606
Oxybutynin Chloride ErOxybutynin Chloride110$2,581
Tamsulosin Hcl235$2,444
Potassium Citrate ErPotassium Citrate16$1,910
Testosterone Cypionate49$1,570
Trospium Chloride14$1,426
Finasteride108$1,030
Methenamine Hippurate16$794
Fesoterodine Fumarate ErFesoterodine Fumarate13$519
Alfuzosin Hcl ErAlfuzosin Hcl42$404

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$48$21,57227 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 368 adult health providers in Virginia.

Other adult health in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →